Neonatal Respiratory Distress Syndrome (RDS)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/61

encourage image

There's no tags or description

Looks like no tags are added yet.

62 Terms

1
New cards

Neonatal RDS

"hyaline membrane disease"; is a respiratory disorder affecting premature infants due to insufficient pulmonary surfactant production causing increased alveolar surface tension, alveolar collapse (atelectasis), decreased lung compliance, impaired gas exchange, hypoxemia and respiratory acidosis

2
New cards

Pulmonary surfactant

is a substance produced by type 2 alveolar pneumocytes that decrease surface tension within the alveoli (prevents alveoli from collapsing especially during expiration)

3
New cards

increases

Surfactant production __________ as the fetal lungs mature (significantly during the 3rd trimester and generally achieve adequate levels around 34-35 weeks of gestation -> so earlier the baby is born the increased likelihood of surfactant deficiency)

4
New cards

1) premature birth (immature type 2 pneumocytes) 2) decreased surfactant production 3) increased alveolar surface tension 4) alveolar collapse (atelectasis) 5) decreased lung compliance and impaired gas exchange 6) hypoxemia, hypercapnia, and respiratory distress

What is the patho of neonatal RDS?

5
New cards

risk factors for RDS

-Prematurity (immature type 2 pneumocytes and inadequate surfactant)

-Maternal DM (can delay fetal surfactant maturation)

-C-Section delivery without labor (less catecholamine-mediated lung fluid clearance)

-Male sex (higher observed RDS risk)

-Multiple gestation (increased likelihood of premature delivery

-Perinatal asphyxia (can impair surfactant function

-Previous sibling with RDS (familial/genetic susceptibility)

6
New cards

s/s of RDS

s/s typically begin immediately after birth or within the first several hrs

-Tachypnea (increased respiratory effort)

-nasal flaring (attempt to decrease airway resistance)

-grunting (helps maintain pos end expiratory pressure)

-intercostal/subcostal retractions (increased work of breathing)

-cyanosis (hypoxemia)

-apnea (severe respiratory compromise

-decrease oxygen sat (impaired gas exchange)

7
New cards

-Chest X-ray: diffuse reticulogranular or ground glass appearance, air bronchograms, low lung volumes, diffuse bilateral pulmonary opacities

-arterial blood gas (ABG): hypoxemia, hypercapnia, respiratory acidosis

-combo dx based on premature gestational age, respiratory distress shortly after birth, characteristic chest X-ray findings, oxygen requirement

How do you dx RDS?

8
New cards

Pulmonary Surfactants

meds administered directly into the lungs to replace deficient endogenous surfactant

9
New cards

1) beractant (Survanta)

2) poractant alfa (Curosurf)

3) calfactant (Infasurf)

What are the 3 major animal-derived surfactants?

10
New cards

Survanta

Beractant

11
New cards

Bovine lung extract containing phospholipids and surfactant proteins SP-B and SP-C supplemented with synthetic lipids

What is the source of Beractant (Survanta)?

12
New cards

Porcine derived phospholipids and hydrophobic surfactant proteins and SP-B and SP-C

What is the source of Poractant alfa (Curosurf)?

13
New cards

Calf lung derived phospholipids and surfactant proteins, including SP-B and SP-C

What is the source of Calfactant (Infasurf)?

14
New cards

25 mg/mL

What is the concentration of Beractant (Survanta)?

15
New cards

80 mg/mL

What is the concentration of Poractant alfa (Curosurf)?

16
New cards

35 mg/mL

What is the concentration of Calfactant (Infasurf)?

17
New cards

100 mg/kg (4 mL/kg)

What is the initial dose of Beractant (Survanta)?

18
New cards

200 mg/kg (2.5 mL/kg)

What is the initial dose of Poractant alfa (Curosurf)?

19
New cards

105 mg/kg (3 mL/kg)

What is the initial dose of Calfactant (Infasurf)?

20
New cards

100 mg/kg

What is the repeat dose of Beractant (Survanta)?

21
New cards

100 mg/kg

What is the repeat dose of Poractant alfa (Curosurf)?

22
New cards

105 mg/kg

What is the repeat dose of Calfactant (Infasurf)?

23
New cards

At least 6 hrs

What is the repeat interval of Beractant (Survanta)?

24
New cards

approximately 12 hrs

What is the repeat interval of Poractant alfa (Curosurf)?

25
New cards

at least 12 hrs

What is the repeat interval of Calfactant (Infasurf)?

26
New cards

4 total

What is the max # of doses in a 48 hr period for Beractant (Survanta)?

27
New cards

3 total

What is the max # of doses in a 48 hr period for Poractant alfa (Curosurf)?

28
New cards

3 total

What is the max # of doses in a 48 hr period for Calfactant (Infasurf)?

29
New cards

Refrigerate 2-8 degrees C

What is the storage of pulmonary surfactants?

30
New cards

warmed

Gently swirl

DO NOT SHAKE

What are the prep considerations for Beractant (Survanta)?

31
New cards

Gently warm to room temp and gently turn vial to mix; DO NOT SHAKE

What are the prep considerations for Poractant alfa (Curosurf)?

32
New cards

Gently swirl

DO NOT SHAKE

DO NOT WARM!

What are the prep considerations for Calfactant (Infasurf)?

33
New cards

pulmonary surfactants MOA

decrease surface tension at the alveolar air-liquid interface, prevent alveolar collapse during expiration, improve lung compliance, increase functional residual capacity, improve oxygenation and ventilation, reduce the work of breathing

34
New cards

improve lung expansion and gas exchange

What is the goal with pulmonary surfactants?

35
New cards

tx of neonatal RDS in premature infants; prevention of RDS in certain high risk premature infants, depending on the specific product

What is the indication of pulmonary surfactants?

36
New cards

administered directly into the lungs through an endotracheal tube or another approved airway delivery technique

What is the administration of pulmonary surfactants?

37
New cards

insure technique, lisa technique, and endotracheal tube admin

What are the techniques used to administer pulmonary surfactants?

38
New cards

INSURE technique

intubation, surfactant admin, rapid extubation to CPAP if clinically appropriate

39
New cards

LISA technique

less invasive, thin catheter is inserted into the trachea, surfactant admin while the infant continues spontaneous breathing on CPAP, avoids prolonged mechanical ventilation

40
New cards

Endotracheal tube admin

used in infants already requiring intubation and mechanical ventilation, surfactant is delivered through the endotracheal tube in aliquots or by the product specific admin method

41
New cards

birth weight

The dosing of pulmonary surfactant is based on the infant's _________.

42
New cards

generally well tolerated but admin can cause acute complications (bradycardia, hypotension, oxygen desaturation, endotracheal tube obstruction, pulmonary hemorrhage, reflux of surfactant, apnea)

AEs of pulmonary surfactants:

43
New cards

CPAP (continuous positive airway pressure)

What is used 1st line for supportive respiratory mangement?

44
New cards

supportive respiratory management

CPAP (continuous positive airway pressure); nasal intermittent pos pressure ventilation (NIPPV), mechanical ventilation if respiratory failure develops, high frequency ventilation in selected pts

45
New cards

FiO2 > 0.3 and CPAP pressure of at least 6 cm H2O

When is it indicated to administer a pulmonary surfactant after supportive respiratory management?

46
New cards

supportive care for RDS

maintain temp, fluid balance, nutrition, glucose, electrolytes, BP, minimize infection risk, caffeine when indicated to reduce apnea of prematurity

47
New cards

Therapeutic Effectiveness with pulmonary surfactants

SpO2 (improves toward target range), FiO2 requirement (decreases), PaO2 (increases toward acceptable range), PaCO2 (improves toward normal), RR (decreases toward age appropriate range), work of breathing (decreases), lung compliance (improves), chest X ray (may show improved lung expansion)

48
New cards

HR (bradycardia), BP (hypotension), SpO2 (oxygen desaturation), Airway patency (ETT obstruction), respiratory status (apnea or worsening distress), lung assessment (pulmonary hemorrhage or pneumothorax), blood gasses (hypoxemia, hypercapnia, respiratory acidosis)

What is the safety monitoring for pulmonary surfactants?

49
New cards

rapid

You should assess ventilator settings after admin of surfactants bc they can cause a _________ improvement in lung compliance.

50
New cards

Antenatal corticosteroids

are meds given to pregnant women who are at risk of delivering prematurely to accelerate fetal organ maturation, particularly lung development. Can help prevent or reduce the severity of RDS

51
New cards

Betamethasone (Celestone) and Dexamethasone (Decadron)

What are the 2 primary antenatal corticosteroids?

52
New cards

MOA of antenatal corticosteroids

cross the placenta and stimulate fetal lung maturation by promoting type 2 pneumocyte maturation, increase pulmonary surfactant production, increase production of surfactant associated proteins, improve lung compliance, promote maturation of other fetal organs

53
New cards

12 mg IM every 24 hrs x 2 doses (total 24 mg)

What is the Betamethsone dosing?

54
New cards

Celestone Soluspan

Betamethasone

55
New cards

Decadron

Dexamethasone

56
New cards

6 mg IM every 12 hrs x 4 doses (total 24 mg)

What is the Dexamethsone dosing?

57
New cards

May consider corticosteroids depending on resuscitation plans

What is the recommendation for antenatal corticosteroids in the gestation age of < 23 weeks and 6 days?

58
New cards

Recommend antenatal corticosteroids if delivery is expected within 7 days

What is the recommendation for antenatal corticosteroids in the gestational age of 24-33 weeks and 6 days?

59
New cards

May give betamethasone if delivery is expected within 7 days and no previous course was given

What is the recommendation for antenatal corticosteroids in the gestation age of 34-36 weeks and 6 days?

60
New cards

do not recommend

What is the recommendation for antenatal corticosteroids in the gestation age of > or = 37 weeks?

61
New cards

decrease neonatal respiratory distress syndrome, neonatal mortality, intraventricular hemorrhage, necrotizing enterocolitis, and the need for respiratory support in premature infants

What are the benefits of antenatal corticosteroids?

62
New cards

maternal hyperglycemia, need closer glucose monitoring in preg pts with DM, possible neonatal hypoglycemia, particularly late-preterm corticosteroid exposure

What are the maternal and fetal considerations for antenatal corticosteroids?